Golden Pine Ventures (Durham, North Carolina)
Dr. Mehr's extensive experience in the life sciences spans both research and business development. Prior to joining Golden Pine Ventures Dr. Mehr served as Vice President of Business Development for Qualyst, Inc., a privately-held biotechnology company focused on novel and proprietary products that increase the efficiency and effectiveness of drug discovery and development. Dr. Mehr has also led business development at Paradigm Genetics and Laboratory Corporation of America, holding senior roles where he leveraged platform technologies for collaborative applications in drug discovery and development research. Dr. Mehr's considerable deal sheet is valued in excess of one hundred million dollars.
Dr. Mehr is also involved with a number of local non-profit organizations, and in April 2007 was chosen among a select group of people to receive the Triangle Business Journal's 40 Under 40 Leadership Award, acknowledging his accomplishments in business and contributions to the community.
Dr. Mehr received his M.B.A. in strategy from Cornell University's Johnson Graduate School of Management, his Ph.D. in genetics, bacterial pathogenesis and immunology at Northwestern University's Medical Center, and his B.S. in microbiology with honors in genomics, molecular evolution and bioinformatics at the University of Illinois Urbana-Champaign.